Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
Iberer
F
F
Tscheliessnigg
K
K
Halwachs
G
G
Auer
T
T
Wasler
A
A
Petutschnigg
B
B
Schreier
G
G
Müller
H
H
Allmayr
T
T
Prenner
G
G
Hipmair
G
G
Grasser
B
B
Freigassner
M
M
D000956:Antigens, Viral / Q000097:blood*; D000998:Antiviral Agents / Q000008:administration & dosage*; D015415:Biomarkers; D003131:Combined Modality Therapy; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D015774:Ganciclovir / Q000008:administration & dosage*; D016027:Heart Transplantation; D006801:Humans; D007116:Immunization, Passive; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011183:Postoperative Complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011446:Prospective Studies; D014766:Viremia / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology
D000956:Antigens, Viral; D000998:Antiviral Agents; D015415:Biomarkers; D015774:Ganciclovir